DAI

Defibrillation testing is mandatory in patients with subcutaneous implantable cardioverter-defibrillator to confirm appropriate ventricular fibrillation detection

J. B. le Polain de Waroux, S. Ploux, P. Mondoly, R. Eschalier, M. Strik, L. Houard, B. Pierre, S. Buliard, N. Klotz, P. Ritter, M. Haissaguerre, K. Mahfouz, P. Bordachar

Heart Rhythm
1 mai 2018

Résumé

Publication details

Journal
Heart Rhythm
Published
1 mai 2018
DOI
10.1016/j.hrthm.2018.02.013
Topics
DAI
X